CSRT.L Regulatory News (CSRT)

24 June 2015

Consort Medical plc

Notification of Transactions of Directors or

Persons Discharging Managerial Responsibility and Connected Persons

DTR 3.1.4

On 19 June 2015 pursuant to the rules of the Consort Medical plc Deferred Bonus Plan the following Directors/persons discharging managerial responsibilities ("PDMRs") of Consort Medical plc (the "Company"), were granted awards over ordinary shares at a share price of £9.257 ("Shares") in the Company in respect of the financial year 2014/15 as detailed against their name below:

Deferred Bonus Share Award

The award was granted as a nil cost option.

Enquiries: I Ward 01442 867920

Consort Medical plc is an international medical devices company, focused on developing and manufacturing disposable medical devices for drug delivery. The principal business of the Company is the management of Bespak, a global market leader in the manufacture of drug delivery devices for pharmaceutical partner companies, including respiratory, nasal, and injectables products, and the manufacture of devices for the point of care diagnostics market.

The Group has facilities in King's Lynn, Cambridge, Nelson, Milton Keynes and Hemel Hempstead in the UK. Consort Medical is a public company quoted on the premium list of the London Stock Exchange (LSE: CSRT). The Group's website address is www.consortmedical.com.